1. Home
  2. WIX vs AMRX Comparison

WIX vs AMRX Comparison

Compare WIX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$66.76

Market Cap

4.4B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$14.47

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIX
AMRX
Founded
2006
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.0B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
WIX
AMRX
Price
$66.76
$14.47
Analyst Decision
Strong Buy
Buy
Analyst Count
21
4
Target Price
$178.10
$13.25
AVG Volume (30 Days)
2.0M
3.6M
Earning Date
01-01-0001
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.83
EPS
N/A
0.11
Revenue
N/A
N/A
Revenue This Year
$14.56
$10.02
Revenue Next Year
$14.18
$6.51
P/E Ratio
$28.86
$131.82
Revenue Growth
N/A
N/A
52 Week Low
$65.45
$6.69
52 Week High
$207.45
$15.42

Technical Indicators

Market Signals
Indicator
WIX
AMRX
Relative Strength Index (RSI) 29.11 56.97
Support Level $65.45 $14.55
Resistance Level $70.19 $15.42
Average True Range (ATR) 4.34 0.41
MACD -0.41 -0.04
Stochastic Oscillator 11.28 48.88

Price Performance

Historical Comparison
WIX
AMRX

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: